Breaking News
Get 45% Off 0
🤖 Are you in? These 5 AI-picked stocks are up 15%+
Read article

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
Starbucks Continues To Innovate With Blonde Espresso Launch By Zacks Investment Research - Jan 09, 2018

In a bid to capitalize on the growing demand for espresso beverages, Starbucks Corporation (NASDAQ:SBUX) has launched a mild version of espresso — Starbucks Blonde Espresso. This is the first...

Zacks Investment Research
Denny's Announces Preliminary Comps Figures For Q4 & 2017 By Zacks Investment Research - Jan 09, 2018

Denny's Corporation (NASDAQ:DENN) , like most other U.S. full-service restaurant chains, has been bearing the brunt of soft consumer spending and sluggish sales owing to the recent hurricanes....

Zacks Investment Research
5 Dividend Growth ETFs For Higher Returns In 2018 By Zacks Investment Research - Jan 09, 2018

A history of dividend growth year over year leads to a healthy portfolio with a greater scope of capital appreciation as opposed to simple dividend paying stocks or those with high yields. Now, with...

Zacks Investment Research
Why Fiat Chrysler (FCAU) Could Beat Earnings Estimates Again By Zacks Investment Research - Jan 09, 2018

Looking for a stock that might be in a good position to beat earnings at its next report? Consider Fiat Chrysler Automobiles N.V. (NYSE:FCAU) , a firm in the Automotive - Foreign, which could be a...

Zacks Investment Research
Boston Scientific (BSX) Surges: Stock Moves 8.3% Higher By Zacks Investment Research - Jan 09, 2018

Boston Scientific Corporation (NYSE:BSX) was a big mover last session, as the company saw its shares rise more than 8% on the day. The move came on solid volume too with far more shares changing...

Zacks Investment Research
Why Penn Virginia (PVAC) Could Be Positioned For A Surge By Zacks Investment Research - Jan 09, 2018

Penn Virginia Corporation (NASDAQ:PVAC) is an independent oil and gas company that could be an interesting play for investors. That is because, not only does the stock have decent short-term...

Zacks Investment Research
Alder BioPharmaceuticals (ALDR) Jumps: Stock Rises 15.5% By Zacks Investment Research - Jan 09, 2018

Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR) was a big mover last session, as the company saw its shares rise more than 15% on the day. The move came on solid volume too with far more shares...

Continue with Apple
Continue with Google
or
Sign up with Email